| Literature DB >> 28353652 |
Xiuling Wang1, Hong Zhang2, Jian Liu3, Rong Chen4,5, Yong Tang6,7, Haixia Chen8, Li Gu9, Mao Li10, Shousong Cao11, Dalian Qin12, Jianming Wu13.
Abstract
Neuronal apoptosis plays a critical role in the pathogenesis of Alzheimer's disease (AD). Previous studies have shown that lychee seed saponins (LSS), isolated and extracted from traditional Chinese medicine lychee seeds, possess many beneficial activities including anti-oxidation, anti-diabetes, anti-AD, etc. In the present study, we established an in vitro neuronal apoptotic model of PC12 cells induced by Aβ25-35 and studied the effect of LSS on apoptosis by the methods of Hoechst 33342/propidium iodide (PI) fluorescence double staining, Annexin V/PI double staining, and terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL). We also investigated the effects of LSS on mitochondria membrane potential, the expressions of Bcl-2 and Bax proteins, and the mRNA expression and the nuclear translocation of NF-κBp65 in PC12 cells. The results showed that LSS markedly inhibited apoptosis, improved the mitochondria membrane potentials, upregulated the expression of Bcl-2 protein, downregulated the expression of Bax protein, and decreased the mRNA expression and nuclear translocation of NF-κBp65 in PC12 cells. The study demonstrated that LSS significantly inhibited apoptosis induced by Aβ25-35 via regulation of the apoptotic and NF-κB pathways in PC12 cells. Therefore, LSS has the potential to be developed as a novel agent or nutrient supplement for the prevention and/or treatment of AD.Entities:
Keywords: Alzheimer’s disease; Aβ25-35; NF-κB; PC12 cells; apoptosis; lychee seed saponins
Mesh:
Substances:
Year: 2017 PMID: 28353652 PMCID: PMC5409676 DOI: 10.3390/nu9040337
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Effect of LSS on apoptosis induced by Aβ25-35 (20 μmol/L) in PC12 cells with Hoechst 33342/PI staining under fluorescence microscope (400×). (A) Representative pictures of PC12 cells treated with or without LSS; (Aa) cells were treated with medium for 13 h without Aβ25-35; (Ab) cells were treated with medium for 1 h and followed by Aβ25-35 for 12 h; (Ac) cells were treated with LSS 0.95 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Ad) cells were treated with LSS 1.90 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Ae) cells were treated with LSS 3.80 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Af) cells were treated with LSS 7.60 mg/L for 1 h and followed by Aβ25-35 for 12 h. The red arrows indicate apoptotic cells; (B) Summarized results of apoptotic ratio. The results are representative of at least three independent experiments run in triplicate and expressed as mean ± SD. ** p < 0.01 vs. cells treated with vehicle and Aβ25-35.
Figure 2Effect of LSS on apoptosis (A) and apoptotic ratio (B) induced by Aβ25-35 (20 μmol/L) in PC12 cells with Annexin V/PI staining by flow cytometric analysis. (Aa) Cells were treated with medium for 13 h without Aβ25-35; (Ab) cells were treated with medium for 1 h and followed by Aβ25-35 for 12 h; (Ac) cells were treated with LSS 0.95 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Ad) cells were treated with LSS 1.90 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Ae) cells were treated with LSS 3.80 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Af) cells were treated with LSS 7.60 mg/L for 1 h and followed by Aβ25-35 for 12 h; (B) Summarized results of apoptotic ratio. The results are representative of at least three independent experiments run in triplicate and expressed as mean ± SD. ** p < 0.01 vs. the cells treated with vehicle and Aβ25-35.
Figure 3Effect of LSS on apoptosis (A) and apoptotic ratio (B) induced by Aβ25-35 (20 μmol/L) in PC12 cells with TUNEL analysis (×400). (Aa) Cells were treated with medium for 13 h without Aβ25-35 ; (Ab) cells were treated with medium for 1 h and followed by Aβ25-35 for 12 h; (Ac) cells were treated with LSS 0.95 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Ad) cells were treated with LSS 1.90 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Ae) cells were treated with LSS 3.80 mg/L for 1 h and followed by Aβ25-35 for 12 h; (Af) cells were treated with LSS 7.60 mg/L for 1 h and followed by Aβ25-35 for 12 h. The red arrows indicate apoptotic cells; (B) Summarized results of apoptotic ratio. The results are representative of at least three independent experiments run in triplicate and expressed as mean ± SD. ** p < 0.01 vs. the cells treated with vehicle and Aβ25-35.
Figure 4Effect of LSS on mitochondria membrane potential in PC12 cells treated with or without Aβ25-35 (20 μmol/L) with rhodamine 123-staining (400×). (a) Cells were treated with medium for 13 h without Aβ25-35; (b) cells were treated with medium for 1 h and followed by Aβ25-35 for 12 h; (c) cells were treated with LSS 0.95 mg/L for 1 h and followed by Aβ25-35 for 12 h; (d) cells were treated with LSS 1.90 mg/L for 1 h and followed by Aβ25-35 for 12 h; (e) cells were treated with LSS 3.80 mg/L for 1 h and followed by Aβ25-35 for 12 h; (f) cells were treated with LSS 7.60 mg/L for 1 h and followed by Aβ25-35 for 12 h. The red arrows indicate apoptotic cells. The results are representative of at least three independent experiments run in triplicate.
Figure 5Effects of LSS on the protein expressions of Bcl-2 (A), Bax (B), and the ratio of Bcl-2/Bax (C) in PC12 cells with or without exposure to 20 μmol/L Aβ25-35 for 12 h. The results are representative of at least three independent experiments run in triplicate and expressed as mean ± SD. ** p < 0.01 vs. the cells treated with Aβ25-35 and vehicle.
Figure 6Effect of LSS on the mRNA expression of NF-κBp65 in PC12 cells treated with Aβ25-35 (20 μmol/L). The results are representative of at least three independent experiments run in triplicate and expressed as mean ± SD. ** p < 0.01 vs. the cells treated with Aβ25-35 and vehicle.
Figure 7Effect of LSS on nuclear translocation of NF-κBp65 in PC12 cells treated with or without 20 μmol/L Aβ25-35 for 12 h (400×). (a) Control cells were treated with medium for 13 h without Aβ25-35; (b) cells were treated with medium for 1 h and followed by 20 μmol/L Aβ25-35 for 12 h; (c) cells were treated with LSS 0.95 mg/L for 1 h and following by 20 μmol/L Aβ25-35 for 12 h; (d) cells were treated with LSS 1.90 mg/L for 1 h and followed by 20 μmol/L Aβ25-35 for 12 h; (e) cells were treated with LSS 3.80 mg/L for 1 h and followed by 20 μmol/L Aβ25-35 for 12 h; (f) cells were treated with LSS 7.60 mg/L for 1 h and followed by 20 μmol/L Aβ25-35 for 12 h. Numbers preceding letters represent the following: 1. red channel (NF-κB); 2. blue channel (DAPI); and 3. combined figure of red and blue channels. The results are representative of at least three independent experiments run in triplicate.
Figure 8Proposed scheme of possible mechanisms for LSS inhibition of apoptosis induced by Aβ25-35 through regulation of the apoptotic and NF-κB pathways in PC12 cells.